SEARCH:
Signup to create an account
test
Icahn Ups the Ante in Bid to Spin Off PayPal

Activist investor Carl Icahn upped the ante in its bid to push eBay Inc. (NASDAQ: EBAY) to spin off PayPal. In a DEF14A filing with the SEC, Mr. Icahn said that the complete disregard for accountability at eBay is the most blatant he's ever seen and strongly urged a number of changes designed to unlock value.

test
Two Ways to Invest in the Wireless Revolution

Most people thought Matt Rogers and Tony Fadell were crazy to leave Apple Inc. (NASDAQ: AAPL) in 2010 to try and start-up a small company focused on wireless home automation.


test
RXi Pharmaceuticals Moves Up to the NASDAQ Stock Exchange

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, has made a lot of progress.

Recent 8K Filings
NORTHWESTERN CORP
OCEANEERING INTERNATIONAL INC
MACK CALI REALTY CORP
HOME BANCORP WISCONSIN, INC.
GRUPO AVAL ACCIONES Y VALORES S.A.
LAREDO RESOURCES CORP.
PATRIOT MINEFINDERS INC.
GREAT PANTHER SILVER LTD
MONARCH CASINO & RESORT INC

Recent Insider Filings
SIGNET JEWELERS LTD (HRABAK EDWARD)
SIGNET JEWELERS LTD (LIGHT MARK)
SIGNET JEWELERS LTD (TRABUCCO ROBERT)
OPKO HEALTH, INC. (FROST PHILLIP MD ET AL)
INNOVATIVE DESIGNS INC (RICCELLI JOSEPH)
CENTRAL EUROPEAN MEDIA ENTERPRISES LTD (BILLOCK JOHN)
UNION FIRST MARKET BANKSHARES CORP (SLAUGHTER RAYMOND L)
CENTRAL EUROPEAN MEDIA ENTERPRISES LTD (SHAPIRIO DOUGLAS S)
LEMAITRE VASCULAR INC (KAMKE TRENT G)



Executive Interview
Aethlon Medical (OTCQB: AEMD)
In this episode of the SECFilings.com Executive Interview Series we speak to Dr. Douglas Taylor, Chief Scientific Officer of Exosome Sciences, wholly owned subsidiary of Aethlon Medical.


Executive Interview
CrowdGather, Inc. (OTCQB: CRWG)
In this episode of the SECFilings.com TV Executive Interview Series we are joined by seasoned entrepreneur Sanjay Sabnani, Chief Executive Officer of CrowdGather, Inc.


Executive Interview
Galectin Therapeutics (NASDAQ: GALT)
In this SECFilings.com Executive Interview we speak with Mr. Jim Czirr, Executive Chairman of Galectin Therapeutics.